Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1924 1
1928 1
1931 1
1932 1
1951 1
1952 1
1972 2
1975 9
1976 15
1977 13
1978 8
1979 17
1980 15
1981 20
1982 19
1983 22
1984 28
1985 30
1986 32
1987 20
1988 41
1989 46
1990 42
1991 54
1992 51
1993 74
1994 93
1995 113
1996 101
1997 128
1998 131
1999 124
2000 163
2001 152
2002 156
2003 160
2004 188
2005 189
2006 194
2007 210
2008 223
2009 241
2010 294
2011 323
2012 363
2013 413
2014 416
2015 427
2016 485
2017 514
2018 618
2019 786
2020 870
2021 4
Text availability
Article attribute
Article type
Publication date

Search Results

7,822 results
Results by year
Filters applied: . Clear all
Page 1
Cannabidiol (CBD) and its analogs: a review of their effects on inflammation.
Burstein S. Burstein S. Bioorg Med Chem. 2015 Apr 1;23(7):1377-85. doi: 10.1016/j.bmc.2015.01.059. Epub 2015 Feb 7. Bioorg Med Chem. 2015. PMID: 25703248 Review.
This was no doubt due to the belief that activity meant psychoactivity that was shown by THC and not by CBD. In retrospect this must be seen as unfortunate since a number of actions of CBD with potential therapeutic benefit were downplayed for many years. ...Topics …
This was no doubt due to the belief that activity meant psychoactivity that was shown by THC and not by CBD. In retrospect this must …
Translational Investigation of the Therapeutic Potential of Cannabidiol (CBD): Toward a New Age.
Crippa JA, Guimarães FS, Campos AC, Zuardi AW. Crippa JA, et al. Front Immunol. 2018 Sep 21;9:2009. doi: 10.3389/fimmu.2018.02009. eCollection 2018. Front Immunol. 2018. PMID: 30298064 Free PMC article. Review.
Background: Among the many cannabinoids in the cannabis plant, cannabidiol (CBD) is a compound that does not produce the typical subjective effects of marijuana. ...Methods: A non-systematic search was performed for studies dealing with therapeutic applications of CBD
Background: Among the many cannabinoids in the cannabis plant, cannabidiol (CBD) is a compound that does not produce the typical subj …
In vivo Evidence for Therapeutic Properties of Cannabidiol (CBD) for Alzheimer's Disease.
Watt G, Karl T. Watt G, et al. Front Pharmacol. 2017 Feb 3;8:20. doi: 10.3389/fphar.2017.00020. eCollection 2017. Front Pharmacol. 2017. PMID: 28217094 Free PMC article. Review.
Importantly, CBD also reverses and prevents the development of cognitive deficits in AD rodent models. Interestingly, combination therapies of CBD and Δ(9)-tetrahydrocannabinol (THC), the main active ingredient of cannabis sativa, show that CBD can antagonize …
Importantly, CBD also reverses and prevents the development of cognitive deficits in AD rodent models. Interestingly, combination the …
Cannabidiol (CBD) use in psychiatric disorders: A systematic review.
Bonaccorso S, Ricciardi A, Zangani C, Chiappini S, Schifano F. Bonaccorso S, et al. Neurotoxicology. 2019 Sep;74:282-298. doi: 10.1016/j.neuro.2019.08.002. Epub 2019 Aug 11. Neurotoxicology. 2019. PMID: 31412258 Review.
Cannabidiol (CBD) and Δ9-tetrahydrocannabinol (THC) are the most represented phytocannabinoids in Cannabis sativa plants. However, CBD may present with a different activity compared with the psychotomimetic THC. Most typically, CBD is reported to be used in s …
Cannabidiol (CBD) and Δ9-tetrahydrocannabinol (THC) are the most represented phytocannabinoids in Cannabis sativa plants. However, …
A Review of Human Studies Assessing Cannabidiol's (CBD) Therapeutic Actions and Potential.
White CM. White CM. J Clin Pharmacol. 2019 Jul;59(7):923-934. doi: 10.1002/jcph.1387. Epub 2019 Feb 7. J Clin Pharmacol. 2019. PMID: 30730563 Review.
The control of refractory seizures is a clear exception, with strong evidence of CBD's benefit. Acute CBD dosing before anxiety-provoking events like public speaking and the chronic use of CBD in schizophrenia are promising but not proven. CBD is not r …
The control of refractory seizures is a clear exception, with strong evidence of CBD's benefit. Acute CBD dosing before anxiet …
CBD: a biomarker database for colorectal cancer.
Zhang X, Sun XF, Cao Y, Ye B, Peng Q, Liu X, Shen B, Zhang H. Zhang X, et al. Database (Oxford). 2018 Jan 1;2018:bay046. doi: 10.1093/database/bay046. Database (Oxford). 2018. PMID: 29846545 Free PMC article.
In this version of the CBD, CRC biomarker data were collected, sorted, displayed and analysed. The CBD with the credible contents as a powerful and time-saving tool provide more comprehensive and accurate information for further CRC biomarker research. ...They can s …
In this version of the CBD, CRC biomarker data were collected, sorted, displayed and analysed. The CBD with the credible conte …
Effects of cannabidiol (CBD) in neuropsychiatric disorders: A review of pre-clinical and clinical findings.
Elsaid S, Kloiber S, Le Foll B. Elsaid S, et al. Prog Mol Biol Transl Sci. 2019;167:25-75. doi: 10.1016/bs.pmbts.2019.06.005. Epub 2019 Aug 28. Prog Mol Biol Transl Sci. 2019. PMID: 31601406 Review.
Moreover, CBD was shown to reduce addictive effects of some drugs of abuse. In clinical studies, CBD was shown to be safe, well-tolerated and efficacious in mitigating the symptoms associated with several types of seizure disorders and childhood epilepsies. ...Curre …
Moreover, CBD was shown to reduce addictive effects of some drugs of abuse. In clinical studies, CBD was shown to be safe, wel …
Potential Adverse Drug Events and Drug-Drug Interactions with Medical and Consumer Cannabidiol (CBD) Use.
Brown JD, Winterstein AG. Brown JD, et al. J Clin Med. 2019 Jul 8;8(7):989. doi: 10.3390/jcm8070989. J Clin Med. 2019. PMID: 31288397 Free PMC article. Review.
Given CBD use among patients with complex conditions and treatment regimens, as well as its expanded consumer use, awareness of potential safety issues with CBD is needed. ...CBD is implicated as both a victim and perpetrator of DDIs and has its own ADE profi …
Given CBD use among patients with complex conditions and treatment regimens, as well as its expanded consumer use, awareness of poten …
Vapor inhalation of cannabidiol (CBD) in rats.
Javadi-Paydar M, Creehan KM, Kerr TM, Taffe MA. Javadi-Paydar M, et al. Pharmacol Biochem Behav. 2019 Sep;184:172741. doi: 10.1016/j.pbb.2019.172741. Epub 2019 Jul 20. Pharmacol Biochem Behav. 2019. PMID: 31336109 Free PMC article.
Separate experiments assessed the body temperature response to CBD in combination with nicotine (30 mg/mL) and the anti-nociceptive response to CBD. RESULTS: Vapor inhalation of CBD produced concentration-related plasma CBD levels in male and female Wi …
Separate experiments assessed the body temperature response to CBD in combination with nicotine (30 mg/mL) and the anti-nociceptive r …
Cannabidiol (CBD) Is a Novel Inhibitor for Exosome and Microvesicle (EMV) Release in Cancer.
Kosgodage US, Mould R, Henley AB, Nunn AV, Guy GW, Thomas EL, Inal JM, Bell JD, Lange S. Kosgodage US, et al. Front Pharmacol. 2018 Aug 13;9:889. doi: 10.3389/fphar.2018.00889. eCollection 2018. Front Pharmacol. 2018. PMID: 30150937 Free PMC article.
CBD significantly reduced exosome release in all three cancer cell lines, and also significantly, albeit more variably, inhibited microvesicle release. ...We suggest that the known anti-cancer effects of CBD may partly be due to the regulatory effects on EMV biogene
CBD significantly reduced exosome release in all three cancer cell lines, and also significantly, albeit more variably, inhibited mic
7,822 results
Jump to page
Feedback